{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:45:15Z","timestamp":1769841915736,"version":"3.49.0"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/femspd\/fty057","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:07:59Z","timestamp":1529406479000},"source":"Crossref","is-referenced-by-count":12,"title":["Vaccine development for enteric bacterial pathogens: Where do we stand?"],"prefix":"10.1093","volume":"76","author":[{"given":"Susmita","family":"Das","sequence":"first","affiliation":[{"name":"Infection Biology Lab, KIIT School of Biotechnology, Campus XI, Bhubaneswar 751024, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal K","family":"Mohakud","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kalinga Institute of Medical Sciences, Patia, Bhubaneswar 751024, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrutyunjay","family":"Suar","sequence":"additional","affiliation":[{"name":"Infection Biology Lab, KIIT School of Biotechnology, Campus XI, Bhubaneswar 751024, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikash R","family":"Sahu","sequence":"additional","affiliation":[{"name":"Infection Biology Lab, KIIT School of Biotechnology, Campus XI, Bhubaneswar 751024, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"key\n\t\t\t\t20180720125855_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet North Am Ed"},{"key":"key\n\t\t\t\t20180720125855_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180720125855_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through Phase I clinical trial in Korea","volume":"29","author":"Baik","year":"2014","journal-title":"J Korean Med Sci"},{"key":"key\n\t\t\t\t20180720125855_bib5","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.vaccine.2014.01.001","article-title":"Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh","volume":"32","author":"Bhuiyan","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib8","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4161\/hv.29241","article-title":"Vaccines against human diarrheal pathogens","volume":"10","author":"Bohles","year":"2014","journal-title":"Hum Vacc Immunother"},{"key":"key\n\t\t\t\t20180720125855_bib9","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"},{"key":"key\n\t\t\t\t20180720125855_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/CVI.00608-15","article-title":"Evaluation of the safety, tolerability, and immunogenicity of an oral, inactivated whole-cell Shigellaflexneri 2a vaccine in healthy adult subjects","volume":"23","author":"Chakraborty","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR Protects against human experimental infection with Vibriocholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib13","first-page":"SC01","article-title":"A study on longevity of immune response after vaccination with Salmonellatyphi Vi conjugate vaccine (PedatyphTM) in children","volume":"9","author":"Chinnasami","year":"2015","journal-title":"J Clin Diagnostic Res"},{"key":"key\n\t\t\t\t20180720125855_bib14","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"Cohen","year":"2002","journal-title":"Infect immunity"},{"key":"key\n\t\t\t\t20180720125855_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3201\/eid0803.010233","article-title":"Human campylobacteriosis in developing countries","volume":"8","author":"Coker","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mi.2009.22","article-title":"Enteric vaccines for the developing world: a challenge for mucosal immunology","volume":"2","author":"Czerkinsky","year":"2009","journal-title":"Mucosal Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/CVI.00364-12","article-title":"The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease","volume":"19","author":"Darsley","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib19","doi-asserted-by":"crossref","first-page":"e0004926","DOI":"10.1371\/journal.pntd.0004926","article-title":"Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a","volume":"10","author":"Darton","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180720125855_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/62.1.113","article-title":"Vaccines against human enteric bacterial pathogens","volume":"62","author":"Dougan","year":"2002","journal-title":"Br Med Bull"},{"key":"key\n\t\t\t\t20180720125855_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria","year":"2005","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180720125855_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1462-5822.2003.00295.x","article-title":"A newborn mouse model for the study of intestinal pathogenesis of shigellosis","volume":"5","author":"Fernandez","year":"2003","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20180720125855_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4081\/jphr.2013.e9","article-title":"Prevalence of gastrointestinal pathogens in developed and developing countries: systematic review and meta-analysis","volume":"2","author":"Fletcher","year":"2013","journal-title":"J Public Health Res"},{"key":"key\n\t\t\t\t20180720125855_bib23a","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib24","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","article-title":"The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers","volume":"73","author":"Garc\u00eda","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib25","doi-asserted-by":"crossref","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180720125855_bib26","doi-asserted-by":"crossref","first-page":"20140143","DOI":"10.1098\/rstb.2014.0143","article-title":"Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response","volume":"370","author":"Gilmartin","year":"2015","journal-title":"Philos T Roy Soc B"},{"key":"key\n\t\t\t\t20180720125855_bib27","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/318457","article-title":"Nontyphoidal salmonellosis","volume":"32","author":"Hohmann","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0264-410X(95)00173-X","article-title":"Evaluation of a phoP\/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers","volume":"14","author":"Hohmann","year":"1996","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/CVI.00378-14","article-title":"Critical analysis of compositions and protective efficacies of oral killed cholera vaccines","volume":"21","author":"Kabir","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180720125855_bib31","first-page":"293","article-title":"Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme","volume":"22","author":"Kaljee","year":"2004","journal-title":"J Heal Popul Nutr"},{"key":"key\n\t\t\t\t20180720125855_bib32","doi-asserted-by":"crossref","first-page":"e99381","DOI":"10.1371\/journal.pone.0099381","article-title":"Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India","volume":"9","author":"Kanungo","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180720125855_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0264-410X(02)00613-8","article-title":"Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichiacoli (ETEC) CS6 antigen","volume":"21","author":"Katz","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/172.4.1126","article-title":"Peru-15, an improved live attenuated oral vaccine candidate for Vibriocholerae O1","volume":"172","author":"Kenner","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib35","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajps.2014.06.002","article-title":"Nanotechnology and vaccine development","volume":"9","author":"Kim","year":"2014","journal-title":"Asian J Pharm Sci"},{"key":"key\n\t\t\t\t20180720125855_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonellaenterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.molmed.2012.04.007","article-title":"Environmental enteropathy: critical implications of a poorly understood condition","volume":"18","author":"Korpe","year":"2012","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20180720125855_bib40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/424680","article-title":"Deletion in the Shigella enterotoxin genes further attenuates Shigellaflexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208","volume":"190","author":"Kotloff","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib41","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"Kotloff","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/hv.4746","article-title":"Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigellaflexneri 2a vaccine grown on animal-free media","volume":"3","author":"Kotloff","year":"2007","journal-title":"Hum Vaccines"},{"key":"key\n\t\t\t\t20180720125855_bib43","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180720125855_bib44","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/IAI.00052-14","article-title":"Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection","volume":"82","author":"Kurtz","year":"2014","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib45","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara","year":"2013","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180720125855_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/QCO.0b013e3282f88b92","article-title":"Shigellosis: the current status of vaccine development","volume":"21","author":"Kweon","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.vaccine.2008.12.021","article-title":"Safety and immunogenicity of SC599, an oral live attenuated Shigelladysenteriae type-1 vaccine in healthy volunteers: results of a phase 2, randomized, double-blind placebo-controlled trial","volume":"27","author":"Launay","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib47a","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00063030-200115001-00002","article-title":"Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration","volume":"15","author":"Lebacq","year":"2001","journal-title":"BioDrugs"},{"key":"key\n\t\t\t\t20180720125855_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180720125855_bib49","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/518141","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonellaenterica Serovar Paratyphi B","volume":"45","author":"Levine","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonellatyphi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180720125855_bib51","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/1471-2105-9-S12-S22","article-title":"Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research","volume":"9","author":"Lin","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20180720125855_bib52","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet North Am Ed"},{"key":"key\n\t\t\t\t20180720125855_bib53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180720125855_bib54","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichiacoli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib55","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum Vacc Immunother"},{"key":"key\n\t\t\t\t20180720125855_bib56","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.vaccine.2009.05.065","article-title":"Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response","volume":"27","author":"Mahalanabis","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib57","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai Ngoc","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180720125855_bib58","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/650733","article-title":"The global burden of nontyphoidal Salmonella gastroenteritis","volume":"50","author":"Majowicz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gut.45.5.633","article-title":"Vaccines against gut pathogens","volume":"45","author":"Mastroeni","year":"1999","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180720125855_bib60","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2007.01.043","article-title":"Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichiacoli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study","volume":"25","author":"McKenzie","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib61","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.vaccine.2008.03.079","article-title":"Safety and immunogenicity of WRSd1, a live attenuated Shigelladysenteriae type 1 vaccine candidate","volume":"26","author":"McKenzie","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib62","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2005.07.014","article-title":"Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigellasonnei: preclinical studies and a phase I trial","volume":"24","author":"McKenzie","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib63","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1039\/C5MB00745C","article-title":"Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichiacoli: a comparative genomics and immunoinformatics approach","volume":"12","author":"Mehla","year":"2016","journal-title":"Mol Biosyst"},{"key":"key\n\t\t\t\t20180720125855_bib64","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1016\/j.vaccine.2015.10.086","article-title":"A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine","volume":"33","author":"Miyazu","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib65","first-page":"779","article-title":"Novel adjuvants & delivery vehicles for vaccines development: a road ahead","volume":"138","author":"Mohan","year":"2013","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t20180720125855_bib66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1309.001","article-title":"Oral tolerance: overview and historical perspectives","volume":"1029","author":"Mowat","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180720125855_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2012-001179","article-title":"Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011","volume":"2","author":"Nichols","year":"2012","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180720125855_bib69","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"P Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180720125855_bib70","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/21645515.2015.1011019","article-title":"Vaccines for viral and bacterial pathogens causing acute gastroenteritis: part I: overview, vaccines for enteric viruses and Vibrio cholerae","volume":"11","author":"O\u2019Ryan","year":"2015","journal-title":"Hum Vacc Immunother"},{"key":"key\n\t\t\t\t20180720125855_bib71","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.vaccine.2007.03.025","article-title":"Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice","volume":"25","author":"Ochoa","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180720125855_bib73","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigellasonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1099\/jmm.0.039180-0","article-title":"The current challenges for vaccine development","volume":"61","author":"Oyston","year":"2012","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180720125855_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180720125855_bib75a","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","article-title":"Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children","volume":"28","author":"Passwell","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.inf.0000078156.03697.a5","article-title":"Safety and immunogenicity of Shigellasonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children","volume":"22","author":"Passwell","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180720125855_bib77","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib78","doi-asserted-by":"crossref","first-page":"120139","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol"},{"key":"key\n\t\t\t\t20180720125855_bib79","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mimet.2011.07.022","article-title":"Differentiation among the Vibriocholerae serotypes O1, O139, O141 and non-O1, non-O139, non-O141 using specific monoclonal antibodies with dot blotting","volume":"87","author":"Pengsuk","year":"2011","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20180720125855_bib80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib81","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2010.10.035","article-title":"Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigellaflexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh","volume":"29","author":"Rahman","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib82","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib83","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.vaccine.2016.02.080","article-title":"Status of vaccine research and development for Campylobacter jejuni","volume":"34","author":"Riddle","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib84","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","article-title":"Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine","volume":"29","author":"Riddle","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib85","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet North Am Ed"},{"key":"key\n\t\t\t\t20180720125855_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180720125855_bib87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tmaid.2006.01.019","article-title":"Campylobacter jejuni proteomics for new travellers\u2019 diarrhoea vaccines","volume":"5","author":"Schrotz-King","year":"2007","journal-title":"Travel Med Infect Di"},{"key":"key\n\t\t\t\t20180720125855_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.carres.2013.03.015","article-title":"Structure of the O-antigen of a novel Shigella flexneri serotype, 1d (I: 7,8)","volume":"373","author":"Shashkov","year":"2013","journal-title":"Carbohydr Res"},{"key":"key\n\t\t\t\t20180720125855_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-8510(00)00132-9","article-title":"Public doubts about vaccination safety and resistance against vaccination","volume":"55","author":"Streefland","year":"2001","journal-title":"Health Policy"},{"key":"key\n\t\t\t\t20180720125855_bib90a","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180720125855_bib91","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet North Am Ed"},{"key":"key\n\t\t\t\t20180720125855_bib92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180720125855_bib93","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14760584.7.6.795","article-title":"Vaccines against enterotoxigenic Escherichia coli","volume":"7","author":"Svennerholm","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180720125855_bib94","first-page":"79","article-title":"Plant-based vaccines against diarrheal diseases","volume":"118","author":"Tacket","year":"2007","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"key\n\t\t\t\t20180720125855_bib95","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1086\/518135","article-title":"CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression","volume":"45","author":"Tacket","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib96","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib97","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/315462","article-title":"Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru","volume":"181","author":"Taylor","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib98","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/IAI.05278-11","article-title":"Engineering and preclinical evaluation of attenuated nontyphoidal salmonella strains serving as live oral vaccines and as reagent strains","volume":"79","author":"Tennant","year":"2011","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180720125855_bib99","article-title":"A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy vietnamese children","volume":"5","author":"Tran","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180720125855_bib17","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM197 Conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"van Damme","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180720125855_bib103","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.17.3.581-611.2004","article-title":"Phase and antigenic variation in bacteria","volume":"17","author":"Van Der Woude","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180720125855_bib104","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.1007\/s00253-015-7000-8","article-title":"The application of virus-like particles as vaccines and biological vehicles","volume":"99","author":"Yan","year":"2015","journal-title":"Appl Microbiol Biot"},{"key":"key\n\t\t\t\t20180720125855_bib88","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1371\/journal.pmed.0030353","article-title":"A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology","volume":"3","author":"Von Seidlein","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180720125855_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib101","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.vaccine.2014.11.049","article-title":"An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180720125855_bib102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3201\/eid0503.990310","article-title":"Adhesins as targets for vaccine development","volume":"5","author":"Wizemann","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180720125855_bib105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/viru.3.1.18447","article-title":"Expression of Escherichiacoli virulence usher protein attenuates wild-type Salmonella","volume":"3","author":"Yang","year":"2012","journal-title":"Virulence"},{"key":"key\n\t\t\t\t20180720125855_bib106","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/89297","article-title":"A plant-based multicomponent vaccine protects mice from enteric diseases","volume":"19","author":"Yu","year":"2001","journal-title":"Nat Biotechnol"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/76\/5\/fty057\/25196343\/fty057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T17:15:37Z","timestamp":1571505337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/fty057\/5040763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":110,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,6,20]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/femspd\/fty057","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,6,20]]}}}